These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 39102508)

  • 21. Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors.
    Wan Y; Li Y; Yan C; Wen J; Tang Z
    Bioorg Chem; 2020 Nov; 104():104217. PubMed ID: 32911192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1).
    Beekman AM; O'Connell MA; Howell LA
    ChemMedChem; 2016 Apr; 11(8):840-4. PubMed ID: 26616140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor.
    Szlavik Z; Csekei M; Paczal A; Szabo ZB; Sipos S; Radics G; Proszenyak A; Balint B; Murray J; Davidson J; Chen I; Dokurno P; Surgenor AE; Daniels ZM; Hubbard RE; Le Toumelin-Braizat G; Claperon A; Lysiak-Auvity G; Girard AM; Bruno A; Chanrion M; Colland F; Maragno AL; Demarles D; Geneste O; Kotschy A
    J Med Chem; 2020 Nov; 63(22):13762-13795. PubMed ID: 33146521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment.
    Xia YL; Wang JJ; Li SY; Liu Y; Gonzalez FJ; Wang P; Ge GB
    Bioorg Med Chem; 2021 Jan; 29():115851. PubMed ID: 33218896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting.
    Slomp A; Moesbergen LM; Gong JN; Cuenca M; von dem Borne PA; Sonneveld P; Huang DCS; Minnema MC; Peperzak V
    Blood Adv; 2019 Dec; 3(24):4202-4214. PubMed ID: 31856269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer.
    Yin YP; Shi WH; Deng K; Liu XL; Li H; Lv XT; Lui VWY; Ding C; Hong B; Lin WC
    Acta Pharmacol Sin; 2021 Aug; 42(8):1298-1310. PubMed ID: 33139838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
    Sun L; Jiang Y; Yan X; Dai X; Huang C; Chen L; Li T; Zhang Y; Xiao H; Yang M; Xiang L; Zhang Y; Chen S; Li S; Chen A; He F; Lian J
    Exp Cell Res; 2021 Sep; 406(1):112755. PubMed ID: 34332981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines.
    Klenke S; Akdeli N; Stelmach P; Heukamp L; Schulte JH; Bachmann HS
    BMC Cancer; 2019 Mar; 19(1):243. PubMed ID: 30885150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
    Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
    Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression.
    Doi K; Liu Q; Gowda K; Barth BM; Claxton D; Amin S; Loughran TP; Wang HG
    Cancer Biol Ther; 2014 Aug; 15(8):1077-86. PubMed ID: 24842334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel biaryl sulfonamide based Mcl-1 inhibitors.
    Follows B; Fessler S; Baumeister T; Campbell AM; Zablocki MM; Li H; Gotur D; Wang Z; Zheng X; Molz L; Nguyen C; Herbertz T; Wang L; Bair K
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2375-2382. PubMed ID: 31235261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models.
    Tesei A; Leonetti C; Zupi G; Scarsella M; Brigliadori G; Ulivi P; Fabbri F; Arienti C; Amadori D; Passardi A; Silvestrini R; Zoli W
    J Cell Mol Med; 2011 Feb; 15(2):316-26. PubMed ID: 20015197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition.
    Bate-Eya LT; den Hartog IJ; van der Ploeg I; Schild L; Koster J; Santo EE; Westerhout EM; Versteeg R; Caron HN; Molenaar JJ; Dolman ME
    Oncotarget; 2016 May; 7(19):27946-58. PubMed ID: 27056887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors.
    Du J; Liu L; Liu B; Yang J; Hou X; Yu J; Fang H
    Future Med Chem; 2020 Jul; 12(14):1293-1304. PubMed ID: 32397829
    [No Abstract]   [Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold.
    Niu Q; Deng H; Zhang Z; Xu Q; Luan S; Huang M; Liu D; Zhao L
    Bioorg Med Chem Lett; 2021 Sep; 47():128215. PubMed ID: 34153472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
    Leverson JD; Zhang H; Chen J; Tahir SK; Phillips DC; Xue J; Nimmer P; Jin S; Smith M; Xiao Y; Kovar P; Tanaka A; Bruncko M; Sheppard GS; Wang L; Gierke S; Kategaya L; Anderson DJ; Wong C; Eastham-Anderson J; Ludlam MJ; Sampath D; Fairbrother WJ; Wertz I; Rosenberg SH; Tse C; Elmore SW; Souers AJ
    Cell Death Dis; 2015 Jan; 6(1):e1590. PubMed ID: 25590800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents.
    Bolomsky A; Vogler M; Köse MC; Heckman CA; Ehx G; Ludwig H; Caers J
    J Hematol Oncol; 2020 Dec; 13(1):173. PubMed ID: 33308268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
    Ling X; Cao S; Cheng Q; Keefe JT; Rustum YM; Li F
    PLoS One; 2012; 7(9):e45571. PubMed ID: 23029106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.
    Zhang S; Li G; Ma X; Wang Y; Liu G; Feng L; Zhao Y; Zhang G; Wu Y; Ye X; Qin B; Lu J
    Cell Signal; 2012 Sep; 24(9):1803-9. PubMed ID: 22609455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models.
    Lu X; Liu YC; Orvig C; Liang H; Chen ZF
    Eur J Med Chem; 2019 Nov; 181():111567. PubMed ID: 31401535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.